🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies

RecruitingNAAges 18 Years - anyFemaleMaxima Medical Center
NCT06859177 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitoring in complicated pregnancies in a home@hospital setting. The primary objective is to assess: • The success rate of the self-administered eCTG measurement The secondary objective is to asses: * Maternal and perinatal outcomes * Patients wellbeing and satisfaction. * Healthcare professionals' (HCPs') satisfaction * Analysis of antenatal costs Participants will: * Self-administer remote eCTG monitoring once daily during admission (or at least twice weekly at the outpatient clinic) * Self-measure their blood pressure, heartrate and temperature * Enter the measurements, symptoms and worries into an application on their telephone. * Answer questionnaires at 3 moments during the study, assessing their wellbeing and satisfaction of

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Minimum age of 18 years old * Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days * Singleton pregnancy * Any indication for fetal monitoring at least twice per week (e.g.): * Pre-eclampsia (PE) * Fetal growth restriction (FGR) * Preterm pre-labor rupture of membranes (PPROM) * Absence of exclusion criteria \> 24 hours after admission. * Oral and written informed consent is obtained. Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * An indication for intravenous medication * Blood pressure \>160/110 A millimeter of mercury (mmHg) * Absent-/or reversed flow umbilical artery Doppler * Hemolysis Elevated Liver enzymes and Low Platelets (HELLP) (Table 1) * Obstetric intervention expected \<48 hours, e.g. due to: * Non reassuring cardiotocography (CTG) * Active vaginal blood loss * Signs of abruption placentae * Meconium stained amniotic fluid * Signs of chorioamnionitis * Patients admitted with a clinical diagnosis of sepsis with hypotension (i.e. septic shock). * Insufficient knowledge of Dutch or English language * Insufficient comprehension of instruction Nemo Remote® or patient information * Fetal and/or maternal cardiac arrhythmias * Contraindications to abdominal patch placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper) * Patients connected to an external or implanted electrical stimulator, such as Transcutaneous Electro Neuro Stimulation (TENS) and pacemaker (because of disturbance of the electrophysiological signal).
💊

What it tests

  • Remote eCTG
📍

Where

1 site
Maxima Medical Center
Veldhoven, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy